| Model Number |
PED-500-30 |
| Medical Device Problem Code |
Activation Failure (3270)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/17/2021
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Medtronic received information regarding two different pipelines that failed to open during a procedure.The patient was undergoing a procedure for flow diverter implantation to treat tandem unruptured saccular aneurysms of an internal carotid artery (ica) ophthalmic segment.The max diameter was 3.74mm and the neck diameter was 5.36mm.Vessel tortuosity was severe.It was reported that all devices were prepared according to the instructions for use (ifu).The catheter was flushed per ifu.A catheter was routinely placed and the pipeline (model: ped-500-35) was prepared.The pipeline was delivered through the catheter and deployment began.The distal segment of the pipeline opened normally but the proximal end failed to open even after multiple attempts.It was discussed and decided to remove the stent to check outside the patient's body.After taking it out, the catheter was found to be damaged and the pipeline could not be pushed out of the catheter normally.A catheter was then replaced with a phenom 27 shapeable catheter was then used and another pipeline (model: ped-500-30) was delivered normally.The distal segment of the pipeline opened normally but the middle section of the pipeline could not be opened even with multiple attempts.The device was resheathed and removed with the phenom 27 microcatheter to observe outside the patient's body.The stent was pushed out from the phenom catheter but still did not open.A pipeline (model: ped-450-20) was then used and implanted successfully.There was no harm or injury to the patient.Post-procedure angiography showed good results.It was noted the patient recovered well.
|
| |
|
Additional Manufacturer Narrative
|
|
H3.Product analysis: the pipeline flex embolization device was returned for analysis within a shipping box, within a plastic bio-pouch, and within an opened pipeline flex inner pouch (b119635).The pipeline flex pusher distal hypotube was found stretched with the shrink tubing pulled back from the proximal bumper.The proximal bumper, resheathing pad, and ptfe sleeves were found in good condition.The tip coil was found bent with the outer coils stretched.The pipeline flex braid ends were found damaged (frayed) and not fully open.As the braid was returned detached from the pusher, the proximal and distal ends could not be identified.Based on the device analysis and reported information, the customer¿s ¿failure/incomplete open proximal¿ report was confirmed.Although the device has been fully deployed and re-sheathed, the pipeline flex braid was not found fully open.It is possible the damage found with the pipeline flex braid and the patient¿s ¿severe¿ vessel tortuosity contributed to the event; however, the cause could not be determined.From the damages seen on the pipeline flex pusher (stretching), it appears excessive force may have been used.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Additional information received reported the first microcatheter used was a marksman microcatheter which was replaced with a phenom 27 microcatheter.There was no issue with the phenom 27.The second pipeline (model: ped-500-30) failed to open at the proximal end.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|